Alterity Therapeutics initiated with a Buy at Craig-Hallum
Buy
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Buy
What happened, with direct paths to the underlying reporting
Analyst update: Craig-Hallum initiates ATHE with Buy and $12 target; current price $4.55; priceChangeSinceSignal +3.41.
Target: $12
Posted price: $4.55
Analyst firm: Craig-Hallum
Analyst: Adam Vogel
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.